Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Crawford A. M., Beasley C. M., Jr, Tollefson G. D. The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations. Schizophr Res. 1997 Jul 25;26(1):41–54. doi: 10.1016/S0920-9964(97)00036-4. [DOI] [PubMed] [Google Scholar]
- Jeste D. V., Rockwell E., Harris M. J., Lohr J. B., Lacro J. Conventional vs. newer antipsychotics in elderly patients. Am J Geriatr Psychiatry. 1999 Winter;7(1):70–76. [PubMed] [Google Scholar]
- Shulman R. W., Ozdemir V. Psychotropic medications and cytochrome P450 2D6: pharmacokinetic considerations in the elderly. Can J Psychiatry. 1997 Jun;42 (Suppl 1):4S–9S. [PubMed] [Google Scholar]
- Solomons K., Geiger O. Olanzapine use in the elderly: a retrospective analysis. Can J Psychiatry. 2000 Mar;45(2):151–155. doi: 10.1177/070674370004500205. [DOI] [PubMed] [Google Scholar]
- Street J. S., Clark W. S., Gannon K. S., Cummings J. L., Bymaster F. P., Tamura R. N., Mitan S. J., Kadam D. L., Sanger T. M., Feldman P. D. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry. 2000 Oct;57(10):968–976. doi: 10.1001/archpsyc.57.10.968. [DOI] [PubMed] [Google Scholar]
- Tollefson G. D., Beasley C. M., Jr, Tran P. V., Street J. S., Krueger J. A., Tamura R. N., Graffeo K. A., Thieme M. E. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry. 1997 Apr;154(4):457–465. doi: 10.1176/ajp.154.4.457. [DOI] [PubMed] [Google Scholar]